Funding Opportunities

• Cancer Research Education Grants Program - Courses for Skills Development (R25 Clinical Trial Not Allowed)
  (PAR-23-276)
  National Cancer Institute
  Application Receipt Date(s): Multiple dates, see announcement.
• Cancer Research Education Grants Program - Research Experiences (R25 Clinical Trial Not Allowed)
  (PAR-23-277)
  National Cancer Institute
  Application Receipt Date(s): Multiple dates, see announcement.
• Cancer Research Education Grants Program - Curriculum or Methods Development (R25 Clinical Trial Not Allowed)
  (PAR-23-278)
  National Cancer Institute
  Application Receipt Date(s): Multiple dates, see announcement.
• Developing novel theory and methods for understanding the genetic architecture of complex human traits (R21 Clinical Trial Not Allowed)
  (PAR-23-301)
  National Human Genome Research Institute
  Application Receipt Date(s): January 7, 2027
• Developing novel theory and methods for understanding the genetic architecture of complex human traits (R01 Clinical Trial Not Allowed)
  (PAR-23-302)
  National Human Genome Research Institute
  Application Receipt Date(s): January 7, 2027
• Health and Health Care Disparities Among Persons Living with Disabilities (R01 - Clinical Trials Optional)
  (PAR-23-309)
  National Institute on Minority Health and Health Disparities
  National Institute on Alcohol Abuse and Alcoholism
  National Institute on Aging
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Cancer Institute
  National Institute on Deafness and Other Communication Disorders
  National Eye Institute
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute of Mental Health
  National Institute of Nursing Research
  National Institute of Neurological Disorders and Stroke
  National Institute of Biomedical Imaging and Bioengineering
  Office of Behavioral and Social Sciences Research
  Application Receipt Date(s): November 5, 2026
• Fc-Dependent Mechanisms of Antibody-Mediated Killing (R01 Clinical Trial Not Allowed)
  (RFA-AI-23-054)
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): January 26, 2024
• Mechanistic Studies of the Effects of Psychosocial Stress on Complex Morbidity Involving SUD, Psychiatric Disorders, and HIV (R01 Clinical Trials Optional)
  (RFA-DA-24-005)
  National Institute on Drug Abuse
  Application Receipt Date(s): February 15, 2024
• Mechanistic Studies of the Effects of Psychosocial Stress on Complex Morbidity Involving SUD, Psychiatric Disorders, and HIV (R01 Basic Experimental Studies with Humans (BESH) Required)
  (RFA-DA-24-006)
  National Institute on Drug Abuse
  Application Receipt Date(s): February 15, 2024
• Mechanistic Research on Neuromodulation for Substance Use Disorders Treatment (R01 Clinical Trial Optional)
  (RFA-DA-24-031)
  National Institute on Drug Abuse
  Application Receipt Date(s): August 14, 2026
• Mechanistic Research on Neuromodulation for Substance Use Disorders Treatment (R01 Basic Experimental Studies with Humans Required)
  (RFA-DA-24-032)
  National Institute on Drug Abuse
  Application Receipt Date(s): August 14, 2026
• Mechanistic Research on Neuromodulation for Substance Use Disorders Treatment (R61/R33 Clinical Trial Optional)
  (RFA-DA-24-033)
  National Institute on Drug Abuse
  Application Receipt Date(s): August 14, 2026
• Seeking Products to Address Social Needs impacting Substance Use Disorders (SUD) (R41/R42 Clinical Trial Optional)
  (RFA-DA-25-047)
  National Institute on Drug Abuse
  Application Receipt Date(s): March 13, 2026
• Seeking Products to Address Social Needs impacting Substance Use Disorders (SUD) (R43/R44 Clinical Trial Optional)
  (RFA-DA-25-048)
  National Institute on Drug Abuse
  Application Receipt Date(s): March 13, 2026
• NIDCR Award for Sustaining Outstanding Achievement in Research (SOAR) (R35 Clinical Trial Not Allowed)
  (RFA-DE-24-006)
  National Institute of Dental and Craniofacial Research
  Application Receipt Date(s): February 13, 2024
• Interventions to Address HIV-Related Comorbidities among Highly Affected Populations Experiencing Health Disparities (R01 - Clinical Trial Required)
  (RFA-MD-24-003)
  National Institute on Minority Health and Health Disparities
  Office of Research on Women's Health
  Application Receipt Date(s): Multiple dates, see announcement.
• Senator Paul D. Wellstone Muscular Dystrophy Specialized Research Centers (MDSRC) (P50 Clinical Trial Optional)
  (RFA-NS-23-032)
  National Institute of Neurological Disorders and Stroke
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  Application Receipt Date(s): November 28, 2023